Syschem (India) Limited (SYSCHEM.BO)
INR 48.01
(-1.84%)
INR 48.01
(-1.84%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.5 Million INR | -71.96% |
| 2022 | 16.05 Million INR | -8.07% |
| 2021 | 17.46 Million INR | -88.52% |
| 2020 | 152.15 Million INR | -7.55% |
| 2019 | 164.57 Million INR | 12.42% |
| 2018 | 146.39 Million INR | -24.06% |
| 2017 | 192.76 Million INR | -6.51% |
| 2016 | 206.18 Million INR | -21.92% |
| 2015 | 264.06 Million INR | -1.8% |
| 2014 | 268.89 Million INR | -12.84% |
| 2013 | 308.49 Million INR | 3.65% |
| 2012 | 297.62 Million INR | 90.38% |
| 2011 | 156.32 Million INR | 277.96% |
| 2010 | 41.36 Million INR | 111.54% |
| 2009 | 19.55 Million INR | -76.97% |
| 2008 | 84.88 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 15.04 Million INR | 0.0% |
| 2023 FY | 4.5 Million INR | -71.96% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 4.5 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q2 | 19.05 Million INR | 0.0% |
| 2022 Q4 | 16.05 Million INR | 0.0% |
| 2022 FY | 16.05 Million INR | -8.07% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 17.46 Million INR | 0.0% |
| 2021 Q2 | 110.17 Million INR | 0.0% |
| 2021 FY | 17.46 Million INR | -88.52% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 154.45 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 152.15 Million INR | 0.0% |
| 2020 FY | 152.15 Million INR | -7.55% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q4 | 164.57 Million INR | 0.0% |
| 2019 FY | 164.57 Million INR | 12.42% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 140.43 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 175.76 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 146.39 Million INR | -24.06% |
| 2018 Q4 | 146.39 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 201.25 Million INR | 0.0% |
| 2017 Q4 | 192.76 Million INR | 0.0% |
| 2017 FY | 192.76 Million INR | -6.51% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q2 | 264.06 Million INR | 0.0% |
| 2016 FY | 206.18 Million INR | -21.92% |
| 2016 Q4 | 196.18 Million INR | 0.0% |
| 2015 Q2 | 248.9 Million INR | 0.0% |
| 2015 Q4 | 264.06 Million INR | 0.0% |
| 2015 FY | 264.06 Million INR | -1.8% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q2 | 274.59 Million INR | 0.0% |
| 2014 Q4 | 268.89 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 268.89 Million INR | -12.84% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 308.49 Million INR | 3.65% |
| 2013 Q2 | 317.49 Million INR | 0.0% |
| 2013 Q4 | 308.49 Million INR | 0.0% |
| 2012 Q4 | 297.62 Million INR | 0.0% |
| 2012 FY | 297.62 Million INR | 90.38% |
| 2011 FY | 156.32 Million INR | 277.96% |
| 2011 Q4 | 156.32 Million INR | 0.0% |
| 2010 FY | 41.36 Million INR | 111.54% |
| 2009 FY | 19.55 Million INR | -76.97% |
| 2008 FY | 84.88 Million INR | 0.0% |
| 2008 Q4 | 84.88 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.56 Million INR | 82.397% |
| KIMIA BIOSCIENCES LIMITED | 437.07 Million INR | 98.97% |
| SHELTER PHARMA LIMITED | 5.77 Million INR | 22.051% |
| Vasundhara Rasayans Limited | 19.46 Million INR | 76.882% |
| Sunil Healthcare Limited | 661.51 Million INR | 99.32% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| MedPlus Health Services Limited | 10.09 Billion INR | 99.955% |
| Bharat Immunologicals & Biologicals Corporation Limited | 702.24 Million INR | 99.359% |
| Patidar Buildcon Limited | 25.32 Million INR | 82.23% |
| Roopa Industries Limited | 258.54 Million INR | 98.259% |
| Smruthi Organics Limited | 117.03 Million INR | 96.155% |
| Trident Lifeline Limited | 184.1 Million INR | 97.556% |
| PANJON LTD. | 14.36 Million INR | 68.683% |
| Pharmaids Pharmaceuticals Limited | 85.32 Million INR | 94.726% |
| Gujarat Terce Laboratories Limited | 38.66 Million INR | 88.362% |
| TIAAN CONSUMER LIMITED | 14.8 Million INR | 69.595% |
| Anuh Pharma Limited | 26.92 Million INR | 83.289% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 1.09 Million INR | -311.335% |
| Sandu Pharmaceuticals Limited | 633 Thousand INR | -610.9% |
| Tyche Industries Limited | - INR | -Infinity% |
| Fredun Pharmaceuticals Limited | 1.05 Billion INR | 99.573% |
| Trimurthi Limited | - INR | -Infinity% |
| Shukra Pharmaceuticals Limited | 31.53 Million INR | 85.732% |
| Norris Medicines Limited | 215.23 Million INR | 97.909% |
| Zenlabs Ethica Limited | 148.59 Million INR | 96.972% |
| Vikram Thermo (India) Limited | 70.43 Million INR | 93.611% |
| ANG Lifesciences India Limited | 728.36 Million INR | 99.382% |
| Parmax Pharma Limited | 53.72 Million INR | 91.624% |
| Veerhealth Care Limited | - INR | -Infinity% |
| Deccan Health Care Limited | 18.95 Million INR | 76.255% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 99.571% |
| Makers Laboratories Limited | 194.92 Million INR | 97.691% |
| Lactose (India) Limited | 392.52 Million INR | 98.854% |
| OXYGENTA PHARMACEUTICAL LIMITE | 572.33 Million INR | 99.214% |
| Zenith Healthcare Limited | - INR | -Infinity% |
| Sanjivani Paranteral Limited. | 9.69 Million INR | 53.565% |
| Bacil Pharma Limited | 984 Thousand INR | -357.317% |
| PRAVEG LIMITED | 596.11 Million INR | 99.245% |
| Denis Chem Lab Limited | 10.46 Million INR | 56.979% |
| Kwality Pharmaceuticals Limited | 981.19 Million INR | 99.541% |
| Jenburkt Pharmaceuticals Limited | - INR | -Infinity% |
| Colinz Laboratories Limited | 5.69 Million INR | 21.025% |
| Godavari Drugs Limited | 556.24 Million INR | 99.191% |
| SHAMROCK INDUSTRIAL CO.LTD. | - INR | -Infinity% |
| Zenotech Laboratories Limited | - INR | -Infinity% |
| Panchsheel Organics Limited | 63.09 Million INR | 92.867% |
| Shree Ganesh Remedies Limited | 364.49 Million INR | 98.765% |
| Vivanza Biosciences Limited | 51.69 Million INR | 91.295% |
| Phaarmasia Limited | 1.44 Million INR | -212.283% |
| Sastasundar Ventures Limited | 38.82 Million INR | 88.41% |
| Medi-Caps Limited | - INR | -Infinity% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Gujarat Themis Biosyn Limited | 27.68 Million INR | 83.745% |
| Ambalal Sarabhai Enterprises Limited | 461.12 Million INR | 99.024% |
| Mercury Laboratories Limited | 55.53 Million INR | 91.897% |
| Gennex Laboratories Limited | 57.2 Million INR | 92.134% |
| BDH Industries Limited | 86.9 Million INR | 94.822% |
| Coral Laboratories Limited | - INR | -Infinity% |
| Concord Drugs Limited | 165.94 Million INR | 97.288% |
| Bharat Parenterals Limited | 1.57 Billion INR | 99.714% |
| Beryl Drugs Limited | 50.93 Million INR | 91.166% |
| Vista Pharmaceuticals Limited | 79.64 Million INR | 94.35% |
| Evoq Remedies Limited | 42.38 Million INR | 89.382% |
| Add-Shop E-Retail Limited | 127.73 Million INR | 96.477% |
| Transchem Limited | - INR | -Infinity% |
| Ishita Drugs and Industries Limited | - INR | -Infinity% |
| Parnax Lab Limited | 806.38 Million INR | 99.442% |
| Source Natural Foods and Herbal Supplements Limited | 35 Thousand INR | -12757.143% |
| Kerala Ayurveda Limited | 675.77 Million INR | 99.334% |
| Cian Healthcare Limited | 556.91 Million INR | 99.192% |
| Trinity League India Limited | 242 Thousand INR | -1759.504% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 99.678% |
| Natural Capsules Limited | 1.09 Billion INR | 99.587% |
| Auro Laboratories Limited | 262.43 Million INR | 98.285% |